NeuroTronik

company

About

Neuro Tronik develops a medical device as an alternative for the drugs used currently to treat heart failures.

Details

Last Funding Type
Series B
Last Funding Money Raised
$23.10M
Industries
Biotechnology,Health Care,Medical Device
Founded date
Jan 1, 2012
Operating Status
Close

NeuroTronik, spun out of medical technology incubator Synecor, is developing a medical device that could take the place of drugs currently used to heart failure. Read more about the company's technology,

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$23.10M
NeuroTronik has raised a total of $23.10M in funding over 2 rounds. Their latest funding was raised on Apr 18, 2017 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 18, 2017 Series B $23.10M 2 Boston Scientific Detail

Investors

Number of Lead Investors
Number of Investors
1
2
NeuroTronik is funded by 2 investors. Boston Scientific and Lord Baltimore Investment Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Boston Scientific Yes Series B
Lord Baltimore Investment Partners Series B